Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis

[1]  N. Beerenwinkel,et al.  Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development , 2017, Scientific Reports.

[2]  G. Rogler,et al.  Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis , 2016, Inflammatory bowel diseases.

[3]  G. Rogler,et al.  The Search for Causative Environmental Factors in Inflammatory Bowel Disease , 2016, Digestive Diseases.

[4]  C. Fiocchi,et al.  Su1869 Submucosal Fibrosis in Ulcerative Colitis Is Linked With Severity and Chronicity of Inflammation , 2016 .

[5]  G. Rogler,et al.  Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis , 2016, Inflammatory bowel diseases.

[6]  J. Goldblum,et al.  Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. , 2014, Inflammatory bowel diseases.

[7]  G. Rogler,et al.  A New Heterotopic Transplant Animal Model of Intestinal Fibrosis , 2013, Inflammatory bowel diseases.

[8]  D. Wraith,et al.  Regulation of Adaptive Immunity; The Role of Interleukin-10 , 2013, Front. Immunol..

[9]  N. Chen,et al.  Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model , 2013, Laboratory Investigation.

[10]  A. Luke,et al.  Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: Impact of a “Top‐Down” approach to intestinal fibrosis in mice , 2012, Inflammatory bowel diseases.

[11]  C. Gasche,et al.  Inflamed gut mucosa: downstream of interleukin‐10 , 2012, European journal of clinical investigation.

[12]  T. Wynn,et al.  Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2. , 2011, Gastroenterology.

[13]  C. Klein,et al.  IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.

[14]  A. Jarry,et al.  Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways. , 2011, Gastroenterology.

[15]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[16]  N. Sebire,et al.  Infant colitis—it's in the genes , 2010, The Lancet.

[17]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[18]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[19]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[20]  M. Netea,et al.  A Crohn's disease–associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1 , 2009, Nature Immunology.

[21]  C. Fiocchi,et al.  Intestinal fibrosis in IBD—a dynamic, multifactorial process , 2009, Nature Reviews Gastroenterology &Hepatology.

[22]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[23]  G. Sharp,et al.  Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. , 2008, The American journal of pathology.

[24]  M. Vatn,et al.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  W. Parks,et al.  Control of matrix metalloproteinase catalytic activity. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[26]  G. Rogler,et al.  Wound healing and fibrosis in intestinal disease , 2006, Gut.

[27]  P. Rutgeerts,et al.  Review article: altering the natural history of Crohn's disease – evidence for and against current therapies , 2006, Alimentary pharmacology & therapeutics.

[28]  Li-juan Zhang,et al.  Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. , 2006, World journal of gastroenterology.

[29]  F. Jain,et al.  IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. , 2004, Experimental and molecular pathology.

[30]  H. Freeman.  Natural History and Clinical Behavior of Crohn's Disease Extending Beyond Two Decades , 2003, Journal of clinical gastroenterology.

[31]  L. Sandkuijl,et al.  A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease. , 2003, Scandinavian journal of gastroenterology.

[32]  F. Carbonnel,et al.  Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.

[33]  J. Devière,et al.  Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[34]  F. Jain,et al.  IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis. , 2002, Experimental and molecular pathology.

[35]  J. Belaiche,et al.  Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease , 2001, Gut.

[36]  P. Rutgeerts,et al.  Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. , 1999, Gastrointestinal endoscopy.

[37]  A. Levine,et al.  References Subscriptions Permissions Email Alerts Resistance of Crohn's Disease T Cells to Multiple Apoptotic Signals Is Associated with a Bcl-2/Bax Mucosal Imbalance , 2013 .

[38]  W. Falk,et al.  Interferon‐gamma (IFN‐γ)‐ and tumour necrosis factor (TNF)‐induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)‐induced colitis in mice , 1999, Clinical and experimental immunology.

[39]  C. Meldrum,et al.  The αvβ6 integrin induces gelatinase B secretion in colon cancer cells , 1999 .

[40]  M. Tomikawa,et al.  Gastrointestinal mucosal regeneration: role of growth factors. , 1999, Frontiers in bioscience : a journal and virtual library.

[41]  D. Cohen,et al.  T cell independence of bleomycin‐induced pulmonary fibrosis , 1999, Journal of leukocyte biology.

[42]  P. Legrand,et al.  Modulation of nitric oxide production in RAW 264.7 cells by transforming growth factor‐beta and interleukin‐10: differential effects on free and encapsulated immunomodulator , 1997, Journal of leukocyte biology.

[43]  D. Cohen,et al.  Contribution of T Lymphocytes to the Development of Bleomycin‐Induced Pulmonary Fibrosis a , 1996, Annals of the New York Academy of Sciences.

[44]  D. Sheppard,et al.  Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer. , 1996, British Journal of Cancer.

[45]  P. Debré,et al.  Interleukin‐10 inhibits IgE‐mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes , 1995, European journal of immunology.

[46]  R. Sartor.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. , 1995, Gastroenterology clinics of North America.

[47]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[48]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[49]  L. Rittié.  Method for Picrosirius Red-Polarization Detection of Collagen Fibers in Tissue Sections. , 2017, Methods in molecular biology.

[50]  G. Rogler,et al.  Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. , 2017, Gastroenterology.

[51]  C. Meldrum,et al.  The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. , 1999, International journal of cancer.

[52]  北村 聖.  "The New England Journal of Medicine". , 1962, British medical journal.